Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$892,971
-$27,428 QoQ
Shares Held
7,068
+7.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,126
of 2,266 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keel Point, LLC holds $22,441,479 across 10 Drug Manufacturers - General names. GILD ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,474 | $6,215,661 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,633 | $4,707,340 | |
| 3 | LLY |
ELI LILLY & Co
|
3,650 | $4,377,919 | |
| 4 | ABBV |
AbbVie Inc.
|
11,997 | $3,018,925 | |
| 5 | NVS |
Novartis AG
|
6,229 | $976,208 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
7,068 | $892,971 | |
| 7 | AMGN |
Amgen Inc
|
2,204 | $798,112 | |
| 8 | AZN |
Astrazeneca PLC
|
3,042 | $576,824 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $892,971 | 7,068 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $920,399 | 6,604 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $917,113 | 7,472 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $668,553 | 6,023 | Shares | Sole | 2025-12-16 | |
| 2025-06-30 | $687,172 | 6,198 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $665,464 | 5,939 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $402,825 | 4,361 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $399,497 | 4,765 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $233,068 | 3,397 | Shares | Sole | 2024-08-14 | |
| 2020-03-31 | $249,548 | 3,338 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||